Diamyd Medical Return On Equity vs. Revenue
| DMYD-B Stock | SEK 13.60 0.62 4.78% |
For Diamyd Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Diamyd Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Diamyd Medical AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Diamyd Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Diamyd Medical AB over time as well as its relative position and ranking within its peers.
Diamyd |
Diamyd Medical AB Revenue vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Diamyd Medical's current stock value. Our valuation model uses many indicators to compare Diamyd Medical value to that of its competitors to determine the firm's financial worth. Diamyd Medical AB is one of the top stocks in return on equity category among its peers. It also is rated as one of the top companies in revenue category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Diamyd Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Diamyd Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Diamyd Revenue vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Diamyd Medical |
| = | -0.42 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Diamyd Medical |
| = | 454 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Diamyd Revenue vs Competition
Diamyd Medical AB is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Biotechnology industry is currently estimated at about 283.75 Million. Diamyd Medical adds roughly 454,000 in revenue claiming only tiny portion of stocks in Biotechnology industry.
Diamyd Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Diamyd Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Diamyd Medical will eventually generate negative long term returns. The profitability progress is the general direction of Diamyd Medical's change in net profit over the period of time. It can combine multiple indicators of Diamyd Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Diamyd Medical AB , a diabetes company, engages in the development of combination therapies for the treatment of autoimmune diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB in April 2013. Diamyd Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 6 people.
Diamyd Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Diamyd Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Diamyd Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Diamyd Medical's important profitability drivers and their relationship over time.
Use Diamyd Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Diamyd Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diamyd Medical will appreciate offsetting losses from the drop in the long position's value.Diamyd Medical Pair Trading
Diamyd Medical AB Pair Trading Analysis
The ability to find closely correlated positions to Diamyd Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Diamyd Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Diamyd Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Diamyd Medical AB to buy it.
The correlation of Diamyd Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Diamyd Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Diamyd Medical AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Diamyd Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Diamyd Medical position
In addition to having Diamyd Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Heavy Metals Thematic Idea Now
Heavy Metals
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Diamyd Stock
To fully project Diamyd Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Diamyd Medical AB at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Diamyd Medical's income statement, its balance sheet, and the statement of cash flows.